Zobrazeno 1 - 10
of 793
pro vyhledávání: '"Michael L Johnson"'
Autor:
Mantasha Tabassum, Soumya G. Chikermane, Camille Johnson, Noor M. Abdulkareem, Elisabeth M. Wang, Michael L. Johnson, Meghana V. Trivedi
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Background Cardiovascular (CV) disease is a leading cause of death in breast cancer (BC) patients due to the increased age and treatments. While individual β-blockers have been investigated to manage CV complications, various β-blockers ha
Externí odkaz:
https://doaj.org/article/d68bdaebd5e34cefa3a68098abf8e26f
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e98392 (2014)
Understanding factors influencing survival of Pacific salmonids (Oncorhynchus spp.) is essential to species conservation, because drivers of mortality can vary over multiple spatial and temporal scales. Although recent studies have evaluated the effe
Externí odkaz:
https://doaj.org/article/54528e3f00e849e0a1a232c6e9255234
Publikováno v:
Frontiers in Physiology, Vol 1 (2010)
While the activation of the infant hypothalamic-pituitary-gonadal (HPG) axis and the existence of a postnatal gonadotrophin surge were first documented in the early 1970s, study of the longitudinal development of gonadal hormones in infancy, and the
Externí odkaz:
https://doaj.org/article/81c1ca30f34e4d92a5723bf15ba42fea
Autor:
Ravi K. Goyal, Sean D. Candrilli, Susan Abughosh, Hua Chen, Holly M. Holmes, Michael L. Johnson
Publikováno v:
Cancers, Vol 16, Iss 12, p 2168 (2024)
In hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) metastatic breast cancer (MBC), cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) have replaced endocrine therapy alone as the standard of care; however, sev
Externí odkaz:
https://doaj.org/article/b6620fc8e52f4f608fa17c59d2663bfd
Autor:
Yinan Huang, Satabdi Chatterjee, Sandeep K. Agarwal, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 11, Iss , Pp 100296- (2023)
Background: Advances in Disease-Modifying Antirheumatic Drugs (DMARDs) have expanded the treatment landscape for Rheumatoid Arthritis (RA). Guidelines recommend adding either conventional synthetic (cs), biologic (b), or targeted synthetic (ts) DMARD
Externí odkaz:
https://doaj.org/article/f4f76651c906426f83f9cf56bcfd1c1d
Autor:
Matthew A. Wanat, Xin Wang, Rutugandha Paranjpe, Hua Chen, Michael L. Johnson, Marc L. Fleming, Susan M. Abughosh
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 4, Pp 674-683 (2019)
Abstract Background No real‐world data exist on outcomes in patients on anticoagulants and concomitant antiarrhythmic medications. This study aims to compare the safety and effectiveness of apixaban and warfarin, first in patients with nonvalvular
Externí odkaz:
https://doaj.org/article/89ab8a3baa164c5a8fa3806cae4defc7
Autor:
Anjana Mohan, Zahra Majd, Michael L. Johnson, Ekere J. Essien, Jamie Barner, Omar Serna, Esteban Gallardo, Marc L. Fleming, Nancy Ordonez, Marcia M. Holstad, Susan M. Abughosh
Publikováno v:
Drugs & Aging. 40:377-390
Autor:
Ravi K. Goyal, Hua Chen, Susan M. Abughosh, Holly M. Holmes, Sean D. Candrilli, Michael L. Johnson
Publikováno v:
Cancer. 129:1051-1063
Publikováno v:
International Journal of Infectious Diseases, Vol 99, Iss , Pp 373- (2020)
Externí odkaz:
https://doaj.org/article/764e431f914a4dfbacbd4865fc186070
Autor:
Soumya G. Chikermane, Manvi Sharma, Susan M. Abughosh, Rajender R. Aparasu, Meghana V. Trivedi, Michael L. Johnson
Publikováno v:
Breast Cancer Research and Treatment. 195:421-430